- Home
- MITQ vs PRPO Comparison
MITQ vs PRPO Comparison
Compare MITQ & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MITQ
- PRPO
- Stock Information
- Founded
- MITQ N/A
- PRPO N/A
- Country
- MITQ United States
- PRPO United States
- Employees
- MITQ N/A
- PRPO N/A
- Industry
- MITQ Telecommunications Equipment
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- MITQ Telecommunications
- PRPO Industrials
- Exchange
- MITQ Nasdaq
- PRPO Nasdaq
- Market Cap
- MITQ 5.5M
- PRPO 17.1M
- IPO Year
- MITQ 2021
- PRPO N/A
- Fundamental
- Price
- MITQ $0.72
- PRPO $15.75
- Analyst Decision
- MITQ
- PRPO
- Analyst Count
- MITQ 0
- PRPO 0
- Target Price
- MITQ N/A
- PRPO N/A
- AVG Volume (30 Days)
- MITQ 9.8M
- PRPO 16.2K
- Earning Date
- MITQ 05-15-2025
- PRPO 08-12-2025
- Dividend Yield
- MITQ N/A
- PRPO N/A
- EPS Growth
- MITQ N/A
- PRPO N/A
- EPS
- MITQ N/A
- PRPO N/A
- Revenue
- MITQ $18,613,000.00
- PRPO $20,029,000.00
- Revenue This Year
- MITQ N/A
- PRPO N/A
- Revenue Next Year
- MITQ N/A
- PRPO N/A
- P/E Ratio
- MITQ N/A
- PRPO N/A
- Revenue Growth
- MITQ N/A
- PRPO 26.67
- 52 Week Low
- MITQ $0.50
- PRPO $3.90
- 52 Week High
- MITQ $1.55
- PRPO $16.89
- Technical
- Relative Strength Index (RSI)
- MITQ 61.52
- PRPO 76.66
- Support Level
- MITQ $0.63
- PRPO $10.60
- Resistance Level
- MITQ $0.75
- PRPO $11.70
- Average True Range (ATR)
- MITQ 0.06
- PRPO 0.97
- MACD
- MITQ 0.01
- PRPO 0.45
- Stochastic Oscillator
- MITQ 74.86
- PRPO 81.25
About MITQ Moving iMage Technologies Inc.
Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.